In this cross-sectional study 660 HCV mono-infected and HCV/HIV co-infected patients, in three countries (France [59%], Brazil [30%], and Australia [11%]), completed paper or internet-based versions of: two existing HRQL questionnaires, and the PROQOL-HCV pilot. Information concerning symptoms, sociodemographic and clinical status were also collected. Psychometric item analysis and factor analysis (CFA) reduced the pilot 72-item PROQOL-HCV questionnaire. Next, reliability (Cronbach´s alpha), convergent validity (EQ-5D, SF-12, symptoms), and clinical validity (biological markers) were assessed using correlation and two-group comparison at a fixed 5% level. Statistical analysis were carried out using the R and Mplus software.
Objectives

Methods
In this cross-sectional study 660 HCV mono-infected and HCV/HIV co-infected patients, in three countries (France [59%] , Brazil [30%] , and Australia [11%]), completed paper or internet-based versions of: two existing HRQL questionnaires, and the PROQOL-HCV pilot. Information concerning symptoms, sociodemographic and clinical status were also collected. Psychometric item analysis and factor analysis (CFA) reduced the pilot 72-item PROQOL-HCV questionnaire. Next, reliability (Cronbach´s alpha), convergent validity (EQ-5D, SF-12, symptoms), and clinical validity (biological markers) were assessed using correlation and two-group comparison at a fixed 5% level. Statistical analysis were carried out using the R and Mplus software.
Results
The sample comprised 57% men and 43% women, aged on average 52 years, 80% vocational level and higher, 35% lived alone, 35% were coinfected with HIV (95% treated); 85% receiving anti-viral treatment: 25% interferon, 35% ribavirin, 43% Direct-Acting Antivirals (35% interferonfree); 27% depressive (71% treated). [ Table 1 ]
Conclusion
The PROQOL-HCV questionnaire demonstrates validity and encompasses new dimensions of Intimate Relationships, Social Health and Treatment Impact. ( 73) 21% (127) a b c represent the lower quartile a, the median b, and the upper quartile c for continuous variables. N is the number of non-missing values. Numbers after percents are frequencies. Lower HRQL (PH, EH, CF) was reported by women (p < 0.01) [ Figure 1 ], depressive patients (p < 0.001), patients on interferon (p < 0.01, except CF), and untreated patients (p < 0.01).
The PROQOL-HCV questionnaire was reduced to 38 items spanning 7 dimensions scored on a 100- 
